Clinical Commissioning Policy: Doravirine for the treatment of HIV-1 in adults

Source:
NHS England
Publisher:
NHS England
Publication date:
02 December 2019

Abstract

Doravirine will be routinely commissioned in line with cost-based, regional prescribing guidelines for the treatment of adults with HIV-1 who have no past or present evidence of resistance to the NNRTI class.